Epoch Investment Partners, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1305841
New York, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$116,508,448
-$67,940,035 QoQ
Shares Held
186,850
-21.7% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#70
of 1,329 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $202,712,087 across 3 Biotechnology names. REGN ranks #1 (57.5% of the industry book) .
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,508,448 | 186,850 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $184,448,483 | 238,725 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $217,154,045 | 281,335 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $145,713,956 | 259,153 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $106,604,925 | 203,057 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $131,574,817 | 207,456 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $140,518,488 | 197,266 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $165,822,596 | 157,740 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $171,628,994 | 163,296 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $99,666,800 | 103,551 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||